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Background: Ventilator-induced lung injury with subsequent bronchopulmonary 
dysplasia remains an important issue in the care of extremely low-birth-weight infants. 
Permissive hypercapnia has been proposed to reduce lung injury. Hypercapnia changes 
cerebral perfusion, but its influence on the peripheral microcirculation is unknown.
Methods: Data were collected from 12 infants, who were randomized to a permissive 
high PCO2 target group (HTG) or a control group (CG). Inclusion criteria were birth weight 
between 400 and 1,000 g, gestational age from 23 to 28 6/7 weeks, intubation during 
the first 24 h of life, and no malformations. The PCO2 target range was increased step-
wise in both groups for weaning and was always 15 mmHg higher in the HTG than in the 
CG. Skin microvascular parameters were assessed non-invasively with sidestream dark 
field imaging on the inner side of the right arm every 24 h during the first week of life and 
on the 14th day of life.
results: Infants in the HTG had significantly higher max. PCO2 exposure, which was 
associated with a significantly and progressively reduced functional vessel density (FVD, 
p < 0.01). Moreover, there were significant differences in the diameter distribution over 
time, with HTG subjects having fewer small vessels but more large vessels.
Conclusion: High PCO2 levels significantly impaired peripheral microcirculation in 
preterm infants, as shown by a decreased FVD, presumably secondary to peripheral 
vasoconstriction.
iSrCTn: 56143743.
Keywords: microcirculation, hypercapnia, extremely low birth weight infants, functional vessel density, skin 
perfusion
Abbreviations: A/C, assisted/controlled; AUC, area under the curve; BPD, bronchopulmonary dysplasia; ELBI, extremely 
low birth weight infant; SDF, sidestream dark field; FVD, functional vessel density; HTG, high PCO2 target group; HFO, 
high-frequency oscillation; HR, heart rate; IVH, intraventricular hemorrhage; MAP, mean airway pressure; CG, control group; 
OPS, orthogonal polarization spectral; PDA, persistent ductus arteriosus; PEEP, positive end-expiratory pressure; PIP, positive 
inspiratory pressure; SIMV, synchronized intermittent mandatory ventilation; VS, vessel surface.
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inTrODUCTiOn
Most extremely low-birth-weight infants (<1,000  g) require 
respiratory assistance after birth, leading to bronchopulmonary 
dysplasia (BPD), a chronic form of lung disease (1, 2). Permissive 
hypercapnia is a strategy of tolerating higher PCO2 levels for the 
benefit of less aggressive ventilation and therefore less mecha-
nical trauma to the lung (3–7). In randomized trials, ventilatory 
intensities were reduced but resulted in only marginal positive 
effects on clinical outcome (6, 8–11). Concerns about possible 
adverse effects such as intraventricular hemorrhage with con-
secutive developmental impairment, as suggested by retrospec-
tive data (12–15), have not been substantiated in randomized 
controlled trials (6, 8–11). We know that hypercapnia causes 
dilatation of cerebral arterioles with possibly increased risk of 
intracranial bleeding (16). On the level of the microcirculation, 
hypoxia and hypercapnia lead to an increase in perfusion in the 
cerebral cortex of the rat (17, 18).
In the past 10 years, we have learned that disturbances in the 
microcirculation have profound effects on outcome. In sepsis, 
for example, a persistent decrease in functional vessel density 
(FVD) is indicative of poor survival (19, 20). Changes in the 
microcirculation were also observed in many different settings 
such as subarachnoid hemorrhage, congenital heart disease, or 
myocardial ischemia (21–23). In the preterm infant, a persistent 
ductus arteriosus (PDA) significantly changes the microcircula-
tion of the skin (24). In preterm hypotensive newborns, FVD in 
the periphery was significantly elevated in comparison to normo-
tensive infants, suggesting a redistribution of microvascular flow 
as an underlying mechanism for hypotension (25).
Therefore, the microcirculation is an important, but under-
recognized physiologic function with possible impact on 
important clinical outcome parameters. Furthermore, the micro-
circulation may be influenced by PCO2. We sought to measure 
the microcirculation in very preterm infants participating in a 
multicenter randomized controlled trial of different PCO2 target 
ranges (PHELBI) (10). The skin of the preterm infants is a specific 
and easily accessible organ to observe changes in the microcircu-
lation. Our hypothesis was that the cutaneous microcirculation 
might be affected by higher PCO2 levels during permissive hyper-
capnia regarding FVD, diameter distribution, and quality of flow.
MaTErialS anD METHODS
This study was part of the randomized, prospective multicenter 
hypercapnia study (PHELBI, ISRCTN 56143743) (10). Infants 
with gestational ages between 23 and 28 6/7  weeks and birth 
weights between 400 and 1,000 g, who were intubated during the 
first 24 h, were randomized within the next 12 h to either a high 
PCO2 target group (HTG) or a control group (CG) after written 
parental consent. Exclusion criteria were congenital malforma-
tions, chromosomal aberrations, and severe asphyxia [pH < 7.0 
and heart rate (HR) < 100/min at 10 min of life]. All infants who 
participated in the PHELBI trial at our center within a predefined 
time frame of 18 months were included in this study.
During the first 14 days of life, the PCO2 target ranges were 
increased stepwise with the target range in the HTG always 
15 mmHg higher than in the CG. PCO2 levels were kept between 
55 and 65  mmHg in the HTG and 40 and 50  mmHg in the 
CG during the first 3  days, increased to 60–70  mmHg (HTG) 
and 45–55  mmHg (CG) on the fourth day, and increased to 
65–75 mmHg (HTG) and 50–60 mmHg (CG) again on the sev-
enth day until extubation or peak inspiratory pressure <12 cm 
H2O or day 14. At our center, the skin microcirculation of a 
subgroup of randomized infants was evaluated as single-center 
substudy. The institutional review board of the Medical Faculty 
of Ludwig Maximilians University of Munich approved the study 
protocol and the consent forms, and all parents granted written 
informed consent.
Sidestream dark field (SDF) imaging with the handheld video 
microscope “MicroScan” (Microvision Medical, Wallingford, 
Pennsylvania) with a five times magnification was used for the 
assessment of the microcirculation. Monochromatic green 
light (530  nm) emitted from LEDs, surrounding a light guide, 
is absorbed by hemoglobin in the erythrocytes and reflected 
by other tissues or structures. The result is a real-time video of 
perfused vessels to a depth of 3 mm, thus producing a functional 
video of the microcirculation. SDF imaging has been validated 
against conventional capillary microscopy in various studies 
(26–29). We obtained sequences of 15 s on three different areas 
on the right inner upper arm. The sublingual region usually 
preferred for SDF imaging in adults is not feasible in preterm 
infants. In previous studies, the upper arm has been shown to be 
easily accessible and to provide a good image quality (24, 25, 30, 
31). To reduce artifacts by lanugo hair, we chose the inner side of 
the arm. Since a PDA influences the skin microcirculation, we 
consistently used only the right arm to avoid the effects of PDA 
as a confounder (24).
Measurements started on the first day of life and continued 
over the first week in 24-h intervals, and the last measurement 
was obtained on the fourteenth day of life. All measurements 
were done by one investigator (KS). All video loops were ana-
lyzed offline with the microvision analysis software, which offers 
a semiautomatic analysis. Vessels are automatically detected on 
the screen, but individual corrections for artifacts such as hair are 
possible. FVD, which represents total vessel length in millimeter 
per image area in square millimeter, as well as the distribution of 
vessel diameters is subsequently calculated. The latter results in 
the representation of small (<10 μm), medium (10–20 µm), and 
large (20–100 µm) vessels as a percentage of the total vessel length. 
Moreover, quality of flow was analyzed, classifying vessels of a 
quadrant into vessels with “no flow,” “intermittent flow,” “sluggish 
flow,” “continuous flow,” and “hyperdynamic flow.” Normal flow is 
defined as continuous flow and hyperdynamic flow as extremely 
fast flow. No flow and intermittent and sluggish flow stand for 
different stages of hypodynamic and thus pathological flow. Flow 
classification was undertaken on the third, fourth, sixth, seventh, 
and fourteenth day of life and expressed as percentage of ves-
sels with the respective quality of flow. All video analyses were 
performed with the investigator blinded to patient, treatment, 
and time point.
Simple statistical analyses were performed with GraphPadPrism 
5 (GraphPad Software Inc., La Jolla, CA, USA). For each time 
point, three video scans per arm were analyzed, and the mean 
FigUrE 1 | A total number of 12 patients could be included to the study as illustrated in the Consort flow diagram.
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value of a variable was used for statistical analysis. To compare 
both groups over time, we used linear mixed effects regression 
models to account for the dependencies of measurements within 
each infant (fitted with proc mixed, SAS software version 9.4, SAS 
Institute, Cary, NC, USA). Group comparisons for categorical 
variables were performed using the chi-square test or Fisher’s 
exact test as appropriate.
For unpaired comparisons between the two groups, the 
Mann–Whitney U test was used for non-parametric data. For 
paired comparisons, the Wilcoxon signed-rank test was used.
To consider the development of PCO2 exposure between both 
groups, a further linear mixed effects regression model was used. 
For other laboratory values (hematocrit, lactate, and CRP), we 
compared minimal and maximal values over the observation 
period with the Mann–Whitney U test. Because of the exploratory 
nature of our study, the results of the statistical tests should not be 
interpreted as confirmatory. An adjustment for multiple testing 
was not done. p < 0.05 was considered as statistically significant.
The PCO2 levels were monitored by blood gas analyses, using 
arterial blood if available, or capillary blood. CRP levels, hemo-
globin levels, medication, and blood transfusions were extracted 




Twelve preterm infants were enrolled in our study (six from each 
randomization group, see Figure 1). Gender and birth weight dis-
tribution and other variables were similar (Table 1). One infant 
of the HTG group had to be excluded, as it was extubated on day 
2 of life. Another infant of the HTG group died on day 4 of life. 
Microcirculatory and clinical values of this infant were included 
as available. Ventilation parameters such as mean airway pres-
sure, positive end-expiratory pressure (PEEP), positive inspira-
tory pressure (PIP), high-frequency oscillation amplitude, and 
frequency tended to be lower in the HTG group, as expected, but 
not significantly. PCO2 values were significantly higher (Figure 2; 
Table  1). Incubator temperature and humidity, HR, and blood 
pressure did not differ. Other laboratory values, including hemo-
globin, hematocrit, lactate, and CRP, did not differ significantly.
Microcirculatory Variables
Images showed similar vasculature at baseline, but declining ves-
sel density toward the end of the study in the HTG (Figure 3). 
Similar results were determined by the quantitative evaluation.
TaBlE 1 | Clinical data.
High PCO2 target 
group (n = 5)
Control group  
(n = 6)
p Value
Gestational age (weeks)a 24 2/7  
(23 3/7–27 6/7)
25 4/7 (24 3/ 
7–27 2/7)
n.s.
Birth weight (g)a 685 (590–990) 712 (490–885) n.s.
Male gender 3 (60%) 3 (50%) n.s.
Betamethasone 5 (100%) 6 (100%) n.s.
Tracheal ventilation on day 14 3 (75%) 6 (100%) n.s.
Average PCO2 expositionb 56 (53–63) 51 (48–54) 0.03
Catecholamine treatment 1 (20%) 4 (80%) n.s.
Min. Hct% 31 (29–35) 30 (28–39) n.s.
Max. lactate (mmol/l) 2.6 (1.3–11.6) 3.2 (1.7–5.8) n.s.
Max. CRP (mg/l) 0.7 (0.3–3.8) 2.3 (0.2–8.2) n.s.
aMedian (minimum–maximum), Mann–Whitney U test.
bMedian (minimum–maximum), Wilcoxon rank sum test.
All others: n (%), Fisher’s exact test.
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FigUrE 2 | PCO2 minima and maxima in the high PCO2 target group (HTG) and control group (CG) over the course of 14 days after birth. Minimum and maximum 
values of all patients are presented as mean values with SDs. PCO2 target levels were stepwise increased on the fourth and seventh day of life. As intended, PCO2 
levels were higher in the HTG.
Functional Vessel Density
Functional vessel density did not differ at baseline between HTG 
and CG, but decreased significantly over the first week in the 
HTG and remained lower until the end of the study (Figure 4), 
compared to CG. The comparison between groups and the time 
effect was significant (both p <  0.01). Vessel surface (VS) was 
also significantly lower in the HTG group over time (Figure 5, 
p < 0.01 for the between-group comparison and p < 0.01 for the 
time effect).
Diameter
Most detected vessels were small with diameters <10  µm and 
varied between 60 and 80% of vessel density with no significant 
difference between the groups at baseline. In the HTG group, the 
proportion of small vessels significantly decreased (Figure  6), 
and therefore, the proportion of medium and large vessels 
increased significantly over time (Figure  7). This resulted in a 
significant difference between groups in the vessel distribution 
(p < 0.01) with a significant time effect (p < 0.05).
Flow
The flow in most vessels was continuous, and only a small 
fraction <6% had no flow in both groups. There were no sig-
nificant differences between both groups over the time observed. 
The stepwise increases of PCO2 targets on days 4 and 7 were not 
consistently followed by temporary increases of flow to hyperdy-
namic levels in all patients (data not shown).
DiSCUSSiOn
This study demonstrates that 14 days of permissive hypercapnia 
with relatively high PCO2 targets as used in this study have a 
significant impact on the microcirculation of the skin, compared 
to the CG with only mildly elevated targets. We demonstrated a 
significant decrease in FVD, whereas FVD remained constant in 
the CG. Thus, hypercapnia significantly reduced skin perfusion. 
The decrease is more prominent in the second week of permissive 
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FigUrE 3 | Typical image of the microcirculation. (a) Day 1 control group, 
(B) day 14 control group, (C) day 1 high PCO2 target group, and (D) day 14 
high PCO2 target group.
FigUrE 4 | Functional vessel density (FVD) over the course of 14 days. Mean and SD are shown. Overall, FVD was significantly lower in the high PCO2 target group 
(p < 0.01 by a linear mixed effects regression model) and time dependent (p < 0.01).
hypercapnia. This suggests a long-term influence of higher PCO2 
levels on skin capillaries. This is the first study to evaluate the 
influence of hypercapnia on the microcirculation of preterm 
infants over a longer time period (16–18, 32–43). Moreover, we 
demonstrate significant changes in the diameter distribution 
with a shift toward larger vessels in the HTG group. At the same 
time, other clinical parameters as well as ventilation parameters 
such as PIP and PEEP did not differ between both groups. Thus, 
the only difference between both groups relevant for our meas-
urements can be seen in the partial pressure of arterial CO2.
Peripheral oxygenation is essential for preserving organ 
function (44). Macrocirculatory parameters are only a poor 
indicator for tissue oxygen delivery (19). SDF imaging provides a 
non-invasive technique to visualize peripheral vasoregulation by 
using a microscope at the bedside.
The reduction of FVD and VS may be the result of a PCO2-
dependent redistribution of blood flow. Respiratory-induced 
changes in the partial pressure of arterial CO2 also play a major 
role in the regulation of cerebral blood flow (45). Hypercapnia 
leads to vasodilatation of cerebral arterioles, whereas hypocapnia 
leads to vasoconstriction and a subsequent decrease in cerebral 
arterial flow (46). Therefore, one would have expected a higher 
FVD in the HTG group, but the opposite effect was found. One 
possible explanation may be concurrent hypercapnia-induced 
vasodilatation in deeper areas of the body, including, but not 
limited, the brain, which may have drawn blood supply away 
from the skin, leading to a compensatory vasoconstriction and 
thus explaining the effects observed in this study.
Alternatively, high PCO2 may have a direct negative effect 
on skin perfusion. Both suggested mechanisms would lead to a 
redistribution of the blood volume toward larger vessels in the 
deeper areas.
Another possible explanation for a reduction in FVD and VS 
may be the so-called Bohr effect. Raised PCO2 levels and a low pH 
reduce the oxygen affinity of hemoglobin and facilitate oxygen 
unloading, thus enhancing oxygen diffusion from hemoglobin to 
the tissues (32, 34). Therefore, the lower FVD does not need to be 
a negative effect; it could also be a sign of better tissue oxygena-
tion while reducing the need for perfused blood vessels.
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FigUrE 5 | Vessel surface (VS) over the course of 14 days. Mean and SD are shown. Overall, VS was significantly lower in the high PCO2 target group (p < 0.01 for 
the between groups comparison, p < 0.01 for the time effect).
FigUrE 6 | Distribution of small vessels over the course of 14 days. Mean and SD are shown. In the high PCO2 target group, the proportion of small vessels 
significantly decreased resulting in a significant difference between groups in the vessel distribution (p < 0.01).
A fourth possible explanation for the reduction in FVD may 
be vasodilation due to high PCO2 values, which could explain the 
larger proportion of medium and large vessels observed in our 
HTG group. As a compensatory mechanism, small vessels would 
constrict and would result in a reduced overall FVD and VS due 
to hypercapnia.
Therefore, the significant changes in diameter distribution 
seem to be another interesting finding in our study. After birth, 
both groups showed a similar distribution of vessel diameter. 
When analyzed on the fourteenth day, the fraction of small vessels 
had decreased in the HTG, while it increased in the CG. In return, 
medium and large vessels were more prominent in the HT group.
Komori et  al. (36) described proportionate increasing 
diameters and velocity while increasing PCO2 up to levels of 
80 mmHg in rabbits. Hudetz et al. (18) obtained similar results 
when studying the effects of hypercapnia in the capillaries of 
the rat cerebral cortex. The increasing diameters are consistent 
with our observation that the proportion of medium and large 
vessels increases with higher PCO2 levels. However, we cannot 
confirm the increased velocity, because even though the fraction 
of hyperdynamic flow appeared to increase with higher PCO2 
targets, this did not reach statistical significance in our study. 
In sepsis models, similar microcirculatory changes indicated a 
poorer outcome (47, 48).
Due to the strict exclusion criteria and the very time-consuming 
methods and analyses, our study population was rather small and 
random errors cannot be ruled out. Another limitation might be 
that analyses of the flow were performed semiquantitatively.
The microcirculation is influenced by various factors, such 
as hematocrit and hemoglobin level, incubator temperature, 
blood transfusions, infections, PDA, and gender (16, 18, 24, 28, 
31, 49–52). There were no significant differences in our groups 
concerning these possible confounders. Blood pressure and 
HR showed no significant or only individual influence on the 
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FigUrE 7 | Distribution of medium and large vessels over the course of 14 days. Mean and SD are shown. In the high PCO2 target group (HTG), the proportion of 
medium and large vessels significantly increased over time (p < 0.05), resulting in a significant difference between groups in the vessel distribution (p < 0.01).
microcirculation in previous studies (30, 53) and were similar 
in both groups. Catecholamine treatment has been shown to 
increase FVD in premature infants (25), which might be a possible 
confounder in our results. Catecholamine treatment appeared to 
occur more frequently in the CG than the HTG, although this has 
not been statistically significant. However, catecholamines were 
given only for a few days. Effects of catecholamine treatment on the 
microcirculation have been demonstrated only in the first 6 h after 
birth and not after discontinuation of the treatment. Therefore, 
we do not think that catecholamine treatment confounded our 
results, showing long-term reduction in FVD seen in the HTG.
Another possible limitation is the lack of measurements 
between the seventh and the fourteenth day. We had decided 
beforehand to concentrate on the immediate effects after eleva-
tion of PCO2 as well as the long-term effects under treatment with 
permissive hypercapnia and not to focus on single data points.
Vascular development is a key process in lung development, 
and impaired vascular development has been linked to the emer-
gence of BPD. Due to our small patient group, we were unable to 
detect significant differences in clinical outcome. However, if we 
look at the missing benefit or even worsened pulmonary outcome 
of the patients of the HTG group in the PHELBI trial (10), we 
speculate that the pulmonary outcome may have been linked 
to the differences in microcirculation. If lung vessels respond 
in the same manner as skin vessels, the reduced vessel density 
after prolonged hypercapnia observed in this study may be one 
possible additional mechanism why permissive hypercapnia as 
performed in this study has not fulfilled the hope of reducing 
the incidence of BPD (10). Although flow was not significantly 
impaired in our study, which might be due to the small number of 
patients, a reduction in FVD results in a pronounced transforma-
tion of microvascular architecture, which could be an important 
pathophysiological mechanism in the genesis of BPD.
In conclusion, our study showed a significant decrease in FVD 
after long-term treatment with high PCO2 targets, possibly due 
to flow redistribution toward larger vessels in deeper areas. The 
microcirculation is a sensitive parameter that reacts to changes 
in multiple diseases or conditions. In our case, it provided a 
different perspective on the benefits and disadvantages reported 
under permissive hypercapnia (9) and should be further explored 
in larger studies.
ETHiCS STaTEMEnT
This study was carried out in accordance with the recommenda-
tions of the institutional review board of the Ludwig Maximilians 
University with written informed consent from all subjects. All 
subjects gave written informed consent in accordance with 
the Declaration of Helsinki. The protocol was approved by the 
institutional review board of the Ludwig Maximilians University.
aUTHOr COnTriBUTiOnS
AP-S, KS, ZM, OG, and UT conceived and planned the trial and 
the measurements. KS and ZM carried out the measurements. 
KS did the analysis of the microcirculatory videos and clinical 
data. AP-S, KS, ZM, OG, JD, and UT contributed to the interpre-
tation of the results. JD, UT, and AP-S performed the statistical 
analyses. AP-S took the lead in writing the manuscript. All authors 
provided critical feedback and helped shape the investigations, 
analyses, and the manuscript.
aCKnOWlEDgMEnTS
The study was part of the dissertation of KS.
FUnDing
The main trial was funded by taxpayer funds through the DFG 
(Deutsche Forschungsgemeinschaft DFG TH626-5/1).
8Puchwein-Schwepcke et al. Microcirculatory Effects of Permissive Hypercapnia
Frontiers in Pediatrics | www.frontiersin.org March 2018 | Volume 6 | Article 52
rEFErEnCES
1. Christou H, Brodsky D. Lung injury and bronchopulmonary dysplasia in 
newborn infants. J Intensive Care Med (2005) 20(2):76–87. doi:10.1177/ 
0885066604273494 
2. Suguihara C, Lessa AC. [Strategies to minimize lung injury in extremely low 
birth weight infants]. J Pediatr (Rio J) (2005) 81(1 Suppl):S69–78. 
3. Hagen EW, Sadek-Badawi M, Carlton DP, Palta M. Permissive hypercapnia 
and risk for brain injury and developmental impairment. Pediatrics (2008) 
122(3):e583–9. doi:10.1542/peds.2008-1016 
4. Laffey JG, Honan D, Hopkins N, Hyvelin JM, Boylan JF, McLoughlin P. 
Hypercapnic acidosis attenuates endotoxin-induced acute lung injury. Am 
J Respir Crit Care Med (2004) 169(1):46–56. doi:10.1164/rccm.200205-394OC 
5. Laffey JG, Jankov RP, Engelberts D, Tanswell AK, Post M, Lindsay T, et  al. 
Effects of therapeutic hypercapnia on mesenteric ischemia-reperfusion 
injury. Am J Respir Crit Care Med (2003) 168(11):1383–90. doi:10.1164/rccm. 
2108078 
6. Mariani G, Cifuentes J, Carlo WA. Randomized trial of permissive hyper-
capnia in preterm infants. Pediatrics (1999) 104(5 Pt 1):1082–8. doi:10.1542/
peds.104.5.1082 
7. Sinclair SE, Kregenow DA, Lamm WJ, Starr IR, Chi EY, Hlastala MP. 
Hypercapnic acidosis is protective in an in vivo model of ventilator-induced 
lung injury. Am J Respir Crit Care Med (2002) 166(3):403–8. doi:10.1164/
rccm.200112-117OC 
8. Stark AR. High-frequency oscillatory ventilation to prevent bronchopul-
monary dysplasia – are we there yet? N Engl J Med (2002) 347(9):682–4. 
doi:10.1056/NEJMe020080 
9. Thome UH, Carroll W, Wu TJ, Johnson RB, Roane C, Young D, et al. Outcome 
of extremely preterm infants randomized at birth to different PaCO2 
targets during the first seven days of life. Biol Neonate (2006) 90(4):218–25. 
doi:10.1159/000092723 
10. Thome UH, Genzel-Boroviczeny O, Bohnhorst B, Schmid M, Fuchs H, 
Rohde O, et al. Permissive hypercapnia in extremely low birthweight infants 
(PHELBI): a randomised controlled multicentre trial. Lancet Respir Med 
(2015) 3(7):534–43. doi:10.1016/S2213-2600(15)00204-0 
11. Network SSGotEKSNNR, Carlo WA, Finer NN, Walsh MC, Rich W, 
Gantz MG, et  al. Target ranges of oxygen saturation in extremely preterm 
infants. N Engl J Med (2010) 362(21):1959–69. doi:10.1056/NEJMoa0911781 
12. Fabres J, Carlo WA, Phillips V, Howard G, Ambalavanan N. Both extremes of 
arterial carbon dioxide pressure and the magnitude of fluctuations in arterial 
carbon dioxide pressure are associated with severe intraventricular hemor-
rhage in preterm infants. Pediatrics (2007) 119(2):299–305. doi:10.1542/
peds.2006-2434 
13. Kaiser JR, Gauss CH, Williams DK. The effects of hypercapnia on cerebral 
autoregulation in ventilated very low birth weight infants. Pediatr Res (2005) 
58(5):931–5. doi:10.1203/01.pdr.0000182180.80645.0c 
14. Kaiser JR, Tilford JM, Simpson PM, Salhab WA, Rosenfeld CR. Hospital 
survival of very-low-birth-weight neonates from 1977 to 2000. J Perinatol 
(2004) 24(6):343–50. doi:10.1038/sj.jp.7211113 
15. Miller JD, Carlo WA. Safety and effectiveness of permissive hypercapnia 
in the preterm infant. Curr Opin Pediatr (2007) 19(2):142–4. doi:10.1097/
MOP.0b013e3280895e12 
16. Harkin CP, Schmeling WT, Kampine JP, Farber NE. The effects of hyper- and 
hypocarbia on intraparenchymal arterioles in rat brain slices. Neuroreport 
(1997) 8(8):1841–4. doi:10.1097/00001756-199705260-00010 
17. Bereczki D, Wei L, Otsuka T, Hans FJ, Acuff V, Patlak C, et al. Hypercapnia 
slightly raises blood volume and sizably elevates flow velocity in brain 
microvessels. Am J Physiol (1993) 264(5 Pt 2):H1360–9. 
18. Hudetz AG, Biswal BB, Feher G, Kampine JP. Effects of hypoxia and hyper-
capnia on capillary flow velocity in the rat cerebral cortex. Microvasc Res 
(1997) 54(1):35–42. doi:10.1006/mvre.1997.2023 
19. De Backer D, Creteur J, Preiser JC, Dubois MJ, Vincent JL. Microvascular 
blood flow is altered in patients with sepsis. Am J Respir Crit Care Med (2002) 
166(1):98–104. doi:10.1164/rccm.200109-016OC 
20. Sakr Y, Dubois MJ, De Backer D, Creteur J, Vincent JL. Persistent microcir-
culatory alterations are associated with organ failure and death in patients 
with septic shock. Crit Care Med (2004) 32(9):1825–31. doi:10.1097/01.
CCM.0000138558.16257.3F 
21. Chierego M, Verdant C, De Backer D. Microcirculatory alterations in 
critically ill patients. Minerva Anestesiol (2006) 72(4):199–205. 
22. Elbers PW, Ince C. Mechanisms of critical illness – classifying microcircu-
latory flow abnormalities in distributive shock. Crit Care (2006) 10(4):221. 
doi:10.1186/cc4568 
23. Verdant C, De Backer D. How monitoring of the microcirculation may help 
us at the bedside. Curr Opin Crit Care (2005) 11(3):240–4. doi:10.1097/01.
ccx.0000158849.94225.11 
24. Hiedl S, Schwepcke A, Weber F, Genzel-Boroviczeny O. Microcirculation in 
preterm infants: profound effects of patent ductus arteriosus. J Pediatr (2010) 
156(2):191–6. doi:10.1016/j.jpeds.2009.08.034 
25. Schwepcke A, Weber FD, Mormanova Z, Cepissak B, Genzel-Boroviczeny O. 
Microcirculatory mechanisms in postnatal hypotension affecting premature 
infants. Pediatr Res (2013) 74(2):186–90. doi:10.1038/pr.2013.78 
26. Goedhart PT, Khalilzada M, Bezemer R, Merza J, Ince C. Sidestream 
Dark Field (SDF) imaging: a novel stroboscopic LED ring-based imaging 
modality for clinical assessment of the microcirculation. Opt Express (2007) 
15(23):15101–14. doi:10.1364/OE.15.015101 
27. Groner W, Winkelman JW, Harris AG, Ince C, Bouma GJ, Messmer K, et al. 
Orthogonal polarization spectral imaging: a new method for study of the 
microcirculation. Nat Med (1999) 5(10):1209–12. doi:10.1038/13529 
28. Harris AG, Sinitsina I, Messmer K. Validation of OPS imaging for microvas-
cular measurements during isovolumic hemodilution and low hematocrits. 
Am J Physiol Heart Circ Physiol (2002) 282(4):H1502–9. doi:10.1152/
ajpheart.00475.2001 
29. Mathura KR, Vollebregt KC, Boer K, De Graaff JC, Ubbink DT, Ince C. 
Comparison of OPS imaging and conventional capillary microscopy to study 
the human microcirculation. J Appl Physiol (2001) 91(1):74–8. doi:10.1152/
jappl.2001.91.1.74 
30. Genzel-Boroviczeny O, Strotgen J, Harris AG, Messmer K, Christ F. 
Orthogonal polarization spectral imaging (OPS): a novel method to measure 
the microcirculation in term and preterm infants transcutaneously. Pediatr 
Res (2002) 51(3):386–91. doi:10.1203/00006450-200203000-00019 
31. Weidlich K, Kroth J, Nussbaum C, Hiedl S, Bauer A, Christ F, et al. Changes 
in microcirculation as early markers for infection in preterm infants – an 
observational prospective study. Pediatr Res (2009) 66(4):461–5. doi:10.1203/
PDR.0b013e3181b3b1f6 
32. Cevese A. Coronary circulation: nitric oxide and hypercapnic acidosis. 
Cardiovasc Res (2005) 66(1):7–8. doi:10.1016/j.cardiores.2005.01.022 
33. Fries M, Weil MH, Sun S, Huang L, Fang X, Cammarata G, et al. Increases in 
tissue Pco2 during circulatory shock reflect selective decreases in capillary blood 
flow. Crit Care Med (2006) 34(2):446–52. doi:10.1097/01.CCM.0000196205. 
23674.23 
34. Hickling KG, Joyce C. Permissive hypercapnia in ARDS and its effect on 
tissue oxygenation. Acta Anaesthesiol Scand Suppl (1995) 107:201–8. doi:10.1
111/j.1399-6576.1995.tb04359.x 
35. Kluess HA, Buckwalter JB, Hamann JJ, Clifford PS. Acidosis attenuates P2X 
purinergic vasoconstriction in skeletal muscle arteries. Am J Physiol Heart 
Circ Physiol (2005) 288(1):H129–32. doi:10.1152/ajpheart.00574.2004 
36. Komori M, Takada K, Tomizawa Y, Nishiyama K, Kawamata M, Ozaki M. 
Permissive range of hypercapnia for improved peripheral microcirculation 
and cardiac output in rabbits. Crit Care Med (2007) 35(9):2171–5. doi:10.1097/ 
01.ccm.0000281445.77223.31 
37. Malvin G. Microcirculatory effects of hypoxic and hypercapnic vasocon-
striction in frog skin. Am J Physiol (1993) 264(2 Pt 2):R435–9. 
38. Mazzoni MC, Cragoe EJ Jr, Arfors KE. Systemic blood acidosis in low-flow 
ischemia induces capillary luminal narrowing. Int J Microcirc Clin Exp (1994) 
14(3):144–50. doi:10.1159/000178822 
39. McGillivray-Anderson KM, Faber JE. Effect of acidosis on contraction 
of microvascular smooth muscle by alpha 1- and alpha 2-adrenoceptors. 
Implications for neural and metabolic regulation. Circ Res (1990) 66(6): 
1643–57. doi:10.1161/01.RES.66.6.1643 
40. Nakanishi T, Gu H, Momma K. Effect of acidosis on contraction, intracellular 
pH and calcium in the rabbit mesenteric small artery. J Mol Cell Cardiol  
(1996) 28(8):1715–26. doi:10.1006/jmcc.1996.0161 
41. Nakanishi T, Gu H, Momma K. Developmental changes in the effect of acidosis on 
contraction, intracellular pH, and calcium in the rabbit mesenteric small artery. 
Pediatr Res (1997) 42(6):750–7. doi:10.1203/00006450-199712000-00006 
9Puchwein-Schwepcke et al. Microcirculatory Effects of Permissive Hypercapnia
Frontiers in Pediatrics | www.frontiersin.org March 2018 | Volume 6 | Article 52
42. Okazaki K, Endou M, Okumura F. Involvement of barium-sensitive K+ chan-
nels in endothelium-dependent vasodilation produced by hypercapnia in rat 
mesenteric vascular beds. Br J Pharmacol (1998) 125(1):168–74. doi:10.1038/
sj.bjp.0702048 
43. Wang X, Wu J, Li L, Chen F, Wang R, Jiang C. Hypercapnic acidosis activates 
KATP channels in vascular smooth muscles. Circ Res (2003) 92(11):1225–32. 
doi:10.1161/01.RES.0000075601.95738.6D 
44. De Backer D, Donadello K, Taccone FS, Ospina-Tascon G, Salgado D, Vincent JL. 
Microcirculatory alterations: potential mechanisms and implications for 
therapy. Ann Intensive Care (2011) 1(1):27. doi:10.1186/2110-5820-1-27 
45. Brian JE Jr, Faraci FM, Heistad DD. Recent insights into the regulation of 
cerebral circulation. Clin Exp Pharmacol Physiol (1996) 23(6–7):449–57. doi:
10.1111/j.1440-1681.1996.tb02760.x 
46. Wasserman AJ, Patterson JL Jr. The cerebral vascular response to reduction in 
arterial carbon dioxide tension. J Clin Invest (1961) 40:1297–303. doi:10.1172/
JCI104359 
47. Buchele GL, Ospina-Tascon GA, De Backer D. How microcirculation data 
have changed my clinical practice. Curr Opin Crit Care (2007) 13(3):324–31. 
doi:10.1097/MCC.0b013e3280c1e5c5 
48. De Backer D, Ospina-Tascon G, Salgado D, Favory R, Creteur J, Vincent JL. 
Monitoring the microcirculation in the critically ill patient: current meth-
ods and future approaches. Intensive Care Med (2010) 36(11):1813–25. 
doi:10.1007/s00134-010-2005-3 
49. Perera P, Kurban AK, Ryan TJ. The development of the cutaneous micro-
vascular system in the newborn. Br J Dermatol (1970) 82:86–91. doi:10.111
1/j.1365-2133.1970.tb07993.x
50. Genzel-Boroviczeny O, Christ F, Glas V. Blood transfusion increases func-
tional capillary density in the skin of anemic preterm infants. Pediatr Res 
(2004) 56(5):751–5. doi:10.1203/01.PDR.0000141982.38959.10 
51. Genzel-Boroviczeny O, Seidl T, Rieger-Fackeldey E, Abicht J, Christ F. 
Impaired microvascular perfusion improves with increased incubator tem-
perature in preterm infants. Pediatr Res (2007) 61(2):239–42. doi:10.1203/
pdr.0b013e31802d77a2 
52. Stark MJ, Clifton VL, Wright IM. Sex-specific differences in peripheral 
microvascular blood flow in preterm infants. Pediatr Res (2008) 63(4):415–9. 
doi:10.1203/01.pdr.0000304937.38669.63 
53. De Backer D, Ortiz JA, Salgado D. Coupling microcirculation to systemic 
hemodynamics. Curr Opin Crit Care (2010) 16(3):250–4. doi:10.1097/
MCC.0b013e3283383621 
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be 
construed as a potential conflict of interest.
Copyright © 2018 Puchwein-Schwepcke, Schottmayer, Mormanová, Dreyhaupt, 
Genzel-Boroviczeny and Thome. This is an open-access article distributed under the 
terms of the Creative Commons Attribution License (CC BY). The use, distribution 
or reproduction in other forums is permitted, provided the original author(s) and the 
copyright owner are credited and that the original publication in this journal is cited, 
in accordance with accepted academic practice. No use, distribution or reproduction 
is permitted which does not comply with these terms.
